Giordano, G., De Vita, F., Melisi, D., Vaccaro, V., Zaniboni, A., Zagonel, V., Vasile, E., Passardi, A., Leo, L., Ventriglia, J., Marciano, R., Russano, M., Conca, R., Andreozzi, F., Lucchini, E., Musettini, G., Bertocchi, P., Bergamo, F., Milella, M., & Febbraro, A. (n.d.). 2335 Analysis of activity, efficacy and safety of first line Nab Paclitaxel (Nab-P) and Gemcitabine (G) in advanced pancreatic cancer (APDAC) frail and elderly patients (pts). European journal of cancer, 51, S445–. http://access.bl.uk/ark:/81055/vdc_100030628218.0x00002b